During the past decade, Quintiles Drug Research Unit conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Quintiles Drug Research Unit" #1 sponsor was "Autoimmune Technologies, LLC" with 1 trials, followed by "BTG International Inc." with 1 trials sponsored, "Destiny Pharma Plc" with 1 trials sponsored, "PharmAthene UK Limited" with 1 trials sponsored and "PowderMed" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Quintiles Drug Research Unit" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Quintiles Drug Research Unit" are "Influenza" (2 trials), "Prevention of Bacillus Anthracis (Anthrax) Infection" (1 trials), "Staphylococcus Aureus Infection" (1 trials) and "Vaccine" (1 trials). Many other conditions were trialed in "Quintiles Drug Research Unit" in a lesser frequency.

Most popular intervention types in "Quintiles Drug Research Unit" are "Biological" (3 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Chlorhexidine gluconate 2% topical cloths" (1 trials), "CoVaccine HT" (1 trials), "FF-3 dry powder" (1 trials), "Placebo" (1 trials) and "Placebo nasal gel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Quintiles Drug Research Unit" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Quintiles Drug Research Unit". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Quintiles Drug Research Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Quintiles Drug Research Unit, 3 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".